A series of 3 articles published in the Lancet is dedicated to highlighting the nature of current postsurgical pain management practices, including the use of peri- and postoperative opioids, that are thought to play a part in driving the opioid crisis.
While not conclusive, evidence suggests a positive association between anxiety during childhood and adolescence and subsequent alcohol use disorder.
Opioid-related deaths, particularly those associated with synthetic opioids, increased in the eastern United States between 1999 and 2016, leading to lower life expectancies.
Greater practice restrictions are associated with a lower percentage of nurse practitioners with waivers to prescribe buprenorphine, but no association is seen for physician assistants.
The Food and Drug Administration (FDA) is notifying the public that cases of seizures have been reported following the use of e-cigarettes.
The presence of civil or criminal penalties for OUD diagnosis during pregnancy was associated with the prevalence of OUD diagnosis.
According to the results of a recently published study, FDANxSpray, the FDA-approved Narcan device for nasal administration, was found to yield higher plasma concentrations of naloxone compared to other devices used to treat opioid overdoses.
From 2012 to 2017, the proportion of US adults who perceived electronic-cigarettes to be as harmful as or more harmful than cigarettes increased.
Hearing loss is independently associated with substance use disorders among those aged 49 years and younger.
The current evidence for the efficacy and safety of replacing opioids with medical cannabis for treating opioid addiction does not meet standards for recommendation.